HealthSTAT News
STAT+: Alnylam says Huntington’s drug shows promise in early study
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
Join the argument
House rules →Comments load as you scroll.